Apoptosis is increased and cell proliferation is decreased in out-of-phase endometria from infertile and recurrent abortion patients

Reproductive Biology and Endocrinology

Volumn 8, Issue , 2010, Pages

  Meresman, Gabriela F ^a   Olivares, Carla ^a   Vighi, Susana ^b   Alfie, Margarita ^b   Irigoyen, Marcela ^b   Etchepareborda, Juan J ^b  

^a INST DE BIOL Y MED EXPERIMENTAL   (Argentina)

^b HOSPITAL DE CLÍNICAS JOSÉ DE SAN MARTÍN   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE; CASPASE 3;

ABORTION; APOPTOSIS; ARTICLE; CELL PROLIFERATION; DNA FRAGMENTATION; ENDOMETRIAL DISEASE; HUMAN; IMMUNOHISTOCHEMISTRY; INFERTILITY; MENSTRUAL CYCLE; PROTEIN EXPRESSION; ADULT; BIOPSY; CASE CONTROL STUDY; DOWN REGULATION; ENDOMETRIUM; FEMALE; FEMALE INFERTILITY; METABOLISM; NICK END LABELING; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; PREGNANCY; RECURRENT ABORTION; UPREGULATION;

ABORTION, HABITUAL; ADULT; APOPTOSIS; BIOPSY; CASE-CONTROL STUDIES; CASPASE 3; CELL PROLIFERATION; DOWN-REGULATION; ENDOMETRIUM; FEMALE; HUMANS; IN SITU NICK-END LABELING; INFERTILITY, FEMALE; MENSTRUAL CYCLE; PREGNANCY; UP-REGULATION;

EID: 77958046756     PISSN: None     EISSN: 14777827     Source Type: Journal    
DOI: 10.1186/1477-7827-8-126     Document Type: Article

References (55)

1. Deligdisch L. Hormonal pathology of the endometrium. Mod Pathol 2000, 13:285-294. 10.1038/modpathol.3880050, 10757339.
2. Sheehan KL, Casper RF, Yen SS. Luteal phase defects induced by an agonist of luteinizing hormone-releasing factor: a model for fertility control. Science 1982, 215:170-172. 10.1126/science.6797068, 6797068.
3. Li TC, Tuckerman EM, Laird SM. Endometrial factors in recurrent miscarriage. Hum Reprod Update 2002, 8:43-52. 10.1093/humupd/8.1.43, 11866239.
4. Usadi RS, Groll JM, Lessey BA, Lininger RA, Zaino RJ, Fritz MA, Young SL. Endometrial development and function in experimentally induced luteal phase deficiency. J Clin Endocrinol Metab 2008, 93:4058-4064. 10.1210/jc.2008-0460, 2729203, 18647810.
5. Devoto L, Kohen P, Munoz A, Strauss JF. Human corpus luteum physiology and the luteal-phase dysfunction associated with ovarian stimulation. Reprod Biomed Online 2009, 18(Suppl 2):19-24. 10.1016/S1472-6483(10)60444-0, 19406027.
6. Potdar N, Konje JC. The endocrinological basis of recurrent miscarriages. Curr Opin Obstet Gynecol 2005, 17:424-428. 10.1097/01.gco.0000175363.20094.bd, 15976551.
7. Jones GS. Luteal phase defect: a review of pathophysiology. Curr Opin Obstet Gynecol 1991, 3:641-648.
8. Wuttke W, Pitzel L, Seidlova-Wuttke D, Hinney B. LH pulses and the corpus luteum: the luteal phase deficiency LPD). Vitam Horm 2001, 63:131-158. full_text, 11358113.
9. Fatemi HM. The luteal phase after 3 decades of IVF: what do we know?. Reprod Biomed Online 2009, 19(Suppl 4):4331.
10. Murray MJ, Meyer WR, Zaino RJ, Lessey BA, Novotny DB, Ireland K, Zeng D, Fritz MA. A critical analysis of the accuracy, reproducibility, and clinical utility of histologic endometrial dating in fertile women. Fertil Steril 2004, 81:1333-1343. 10.1016/j.fertnstert.2003.11.030, 15136099.
11. Li TC, Cooke ID. Evaluation of the luteal phase. Hum Reprod 1991, 6:484-499.
12. Honore LH, Cumming DC, Fahmy N. Significant difference in the frequency of out-of-phase endometrial biopsies depending on the use of the Novak curette or the flexible polypropylene endometrial biopsy cannula ('Pipelle'). Gynecol Obstet Invest 1988, 26:338-340.
13. Peters AJ, Lloyd RP, Coulam CB. Prevalence of out-of-phase endometrial biopsy specimens. Am J Obstet Gynecol 1992, 166:1738-1745.
14. Harada T, Kaponis A, Iwabe T, Taniguchi F, Makrydimas G, Sofikitis N, Paschopoulos M, Paraskevaidis E, Terakawa N. Apoptosis in human endometrium and endometriosis. Hum Reprod Update 2004, 10:29-38. 10.1093/humupd/dmh007, 15005462.
15. Li A, Felix JC, Hao J, Minoo P, Jain JK. Menstrual-like breakdown and apoptosis in human endometrial explants. Hum Reprod 2005, 20:1709-1719. 10.1093/humrep/deh824, 15734750.
16. Otsuki Y. Apoptosis in human endometrium: apoptotic detection methods and signaling. Med Electron Microsc 2001, 34:166-173. 10.1007/s007950100011, 11793192.
17. Hopwood D, Levison DA. Atrophy and apoptosis in the cyclical human endometrium. J Pathol 1976, 119:159-166. 10.1002/path.1711190305, 956955.
18. Tao XJ, Tilly KI, Maravei DV, Shifren JL, Krajewski S, Reed JC, Tilly JL, Isaacson KB. Differential expression of members of the bcl-2 gene family in proliferative and secretory human endometrium: glandular epithelial cell apoptosis is associated with increased expression of bax. J Clin Endocrinol Metab 1997, 82:2738-2746. 10.1210/jc.82.8.2738, 9253363.
19. Meresman GF, Vighi S, Buquet RA, Contreras-Ortiz O, Tesone M, Rumi LS. Apoptosis and expression of Bcl-2 and Bax in eutopic endometrium from women with endometriosis. Fertil Steril 2000, 74:760-766. 10.1016/S0015-0282(00)01522-3, 11020520.
20. Meresman GF, Auge L, Baranao RI, Lombardi E, Tesone M, Sueldo C. Oral contraceptives suppress cell proliferation and enhance apoptosis of eutopic endometrial tissue from patients with endometriosis. Fertil Steril 2002, 77:1141-1147. 10.1016/S0015-0282(02)03099-6, 12057719.
21. Tesone M, Bilotas M, Baranao RI, Meresman G. The role of GnRH analogues in endometriosis-associated apoptosis and angiogenesis. Gynecol Obstet Invest 2008, 66(Suppl 1):10-18. 10.1159/000148026, 18936547.
22. Mor G, Abrahams VM. Potential role of macrophages as immunoregulators of pregnancy. Reprod Biol Endocrinol 2003, 1:119-127. 10.1186/1477-7827-1-119, 305335, 14651752.
23. Noyes RW, Hertig AT, Rock J. Dating the endometrial biopsy. Fertil Steril 1950, 1:3-25.
24. Galluzzi L, Aaronson SA, Abrams J, Alnemri ES, Andrews DW, Baehrecke EH, Bazan NG, Blagosklonny MV, Blomgren K, Borner C, Bredesen DE, Brenner C, Castedo M, Cidlowski JA, Ciechanover A, Cohen GM, De LV, De Maria R, Deshmukh M, Dynlacht BD, El Deiry WS, Flavell RA, Fulda S, Garrido C, Golstein P, Gougeon ML, Green DR, Gronemeyer H, Hajnoczky G, Hardwick JM, et al. Guidelines for the use and interpretation of assays for monitoring cell death in higher eukaryotes. Cell Death Differ 2009, 16:1093-1107. 10.1038/cdd.2009.44, 2757140, 19373242.
25. Bilotas M, Meresman G, Stella I, Sueldo C, Baranao RI. Effect of aromatase inhibitors on ectopic endometrial growth and peritoneal environment in a mouse model of endometriosis. Fertil Steril 2010, 93:2513-2518. 10.1016/j.fertnstert.2009.08.058, 19819437.
26. Bravo R, Macdonald-Bravo H. Existence of two populations of cyclin/proliferating cell nuclear antigen during the cell cycle: association with DNA replication sites. J Cell Biol 1987, 105:1549-1554. 10.1083/jcb.105.4.1549, 2114668, 2889739.
27. Kato T, Kameoka S, Kimura T, Nishikawa T, Kobayashi M. C-erbB-2 and PCNA as prognostic indicators of long-term survival in breast cancer. Anticancer Res 2002, 22:1097-1103.
28. Moyer DL, Felix JC. The effects of progesterone and progestins on endometrial proliferation. Contraception 1998, 57:399-403. 10.1016/S0010-7824(98)00047-X, 9693400.
29. Sun WH, Chen GS, Ou XL, Yang Y, Luo C, Zhang Y, Shao Y, Xu HC, Xiao B, Xue YP, Zhou SM, Zhao QS, Ding GX. Inhibition of COX-2 and activation of peroxisome proliferator-activated receptor gamma synergistically inhibits proliferation and induces apoptosis of human pancreatic carcinoma cells. Cancer Lett 2009, 275:247-255. 10.1016/j.canlet.2008.10.023, 19056168.
30. Ben Izhak O, Bar-Chana M, Sussman L, Dobiner V, Sandbank J, Cagnano M, Cohen H, Sabo E. Ki67 antigen and PCNA proliferation markers predict survival in anorectal malignant melanoma. Histopathology 2002, 41:519-525. 10.1046/j.1365-2559.2002.01444.x, 12460204.
31. Turner HE, Wass JA. Are markers of proliferation valuable in the histological assessment of pituitary tumours?. Pituitary 1999, 1:147-151. 10.1023/A:1009979128608, 11081192.
32. Ginsburg KA. Luteal phase defect. Etiology, diagnosis, and management. Endocrinol Metab Clin North Am 1992, 21:85-104.
33. Castelbaum AJ, Wheeler J, Coutifaris CB, Mastroianni L, Lessey BA. Timing of the endometrial biopsy may be critical for the accurate diagnosis of luteal phase deficiency. Fertil Steril 1994, 61:443-447.
34. Bukulmez O, Arici A. Luteal phase defect: myth or reality. Obstet Gynecol Clin North Am 2004, 31:727-44. ix, 10.1016/j.ogc.2004.08.007, 15550332.
35. Coutifaris C, Myers ER, Guzick DS, Diamond MP, Carson SA, Legro RS, McGovern PG, Schlaff WD, Carr BR, Steinkampf MP, Silva S, Vogel DL, Leppert PC. Histological dating of timed endometrial biopsy tissue is not related to fertility status. Fertil Steril 2004, 82:1264-1272. 10.1016/j.fertnstert.2004.03.069, 15533340.
36. Xiao E, Xia-Zhang L, Ferin M. Inadequate luteal function is the initial clinical cyclic defect in a 12-day stress model that includes a psychogenic component in the Rhesus monkey. J Clin Endocrinol Metab 2002, 87:2232-2237. 10.1210/jc.87.5.2232, 11994369.
37. Cunha-Filho JS, Gross JL, Bastos de Souza CA, Lemos NA, Giugliani C, Freitas F, Passos EP. Physiopathological aspects of corpus luteum defect in infertile patients with mild/minimal endometriosis. J Assist Reprod Genet 2003, 20:117-121. 10.1023/A:1022625106489, 12735387.
38. Jones HW. Luteal-phase defect: the role of Georgeanna Seegar Jones. Fertil Steril 2008, 90:e5-e7. 10.1016/j.fertnstert.2007.08.036, 18001720.
39. Jordan J, Craig K, Clifton DK, Soules MR. Luteal phase defect: the sensitivity and specificity of diagnostic methods in common clinical use. Fertil Steril 1994, 62:54-62.
40. Creus M, Balasch J, Ordi J, Fabregues F, Casamitjana R, Quinto L, Coutifaris C, Vanrell JA. Integrin expression in normal and out-of-phase endometria. Hum Reprod 1998, 13:3460-3468. 10.1093/humrep/13.12.3460, 9886534.
41. John M, Rameshkumar K, Lillian DA. Evaluation of luteal phase in normal and infertile women. Indian J Pathol Microbiol 1997, 40:27-31.
42. Hirama Y, Ochiai K. Estrogen and progesterone receptors of the out-of-phase endometrium in female infertile patients. Fertil Steril 1995, 63:984-988.
43. Kokawa K, Shikone T, Nakano R. Apoptosis in the human uterine endometrium during the menstrual cycle. J Clin Endocrinol Metab 1996, 81:4144-4147. 10.1210/jc.81.11.4144, 8923873.
44. Watanabe H, Kanzaki H, Narukawa S, Inoue T, Katsuragawa H, Kaneko Y, Mori T. Bcl-2 and Fas expression in eutopic and ectopic human endometrium during the menstrual cycle in relation to endometrial cell apoptosis. Am J Obstet Gynecol 1997, 176:360-368. 10.1016/S0002-9378(97)70499-X, 9065182.
45. Yamashita H, Otsuki Y, Matsumoto K, Ueki K, Ueki M. Fas ligand, Fas antigen and Bcl-2 expression in human endometrium during the menstrual cycle. Mol Hum Reprod 1999, 5:358-364. 10.1093/molehr/5.4.358, 10321808.
46. Mertens HJ, Heineman MJ, Evers JL. The expression of apoptosis-related proteins Bcl-2 and Ki67 in endometrium of ovulatory menstrual cycles. Gynecol Obstet Invest 2002, 53:224-230. 10.1159/000064569, 12186988.
47. Pecci A, Scholz A, Pelster D, Beato M. Progestins prevent apoptosis in a rat endometrial cell line and increase the ratio of bcl-XL to bcl-XS. J Biol Chem 1997, 272:11791-11798. 10.1074/jbc.272.18.11791, 9115235.
48. Song J, Rutherford T, Naftolin F, Brown S, Mor G. Hormonal regulation of apoptosis and the Fas and Fas ligand system in human endometrial cells. Mol Hum Reprod 2002, 8:447-455. 10.1093/molehr/8.5.447, 11994542.
49. Labied S, Kajihara T, Madureira PA, Fusi L, Jones MC, Higham JM, Varshochi R, Francis JM, Zoumpoulidou G, Essafi A, Fernandez D, Lam EW, Brosens JJ. Progestins regulate the expression and activity of the forkhead transcription factor FOXO1 in differentiating human endometrium. Mol Endocrinol 2006, 20:35-44. 10.1210/me.2005-0275, 16123151.
50. Smith SC, Baker PN, Symonds EM. Increased placental apoptosis in intrauterine growth restriction. Am J Obstet Gynecol 1997, 177:1395-1401. 10.1016/S0002-9378(97)70081-4, 9423741.
51. Allaire AD, Ballenger KA, Wells SR, McMahon MJ, Lessey BA. Placental apoptosis in preeclampsia. Obstet Gynecol 2000, 96:271-276. 10.1016/S0029-7844(00)00895-4, 10908776.
52. Fest S, Brachwitz N, Schumacher A, Zenclussen ML, Khan F, Wafula PO, Casalis PA, Fill S, Costa SD, Mor G, Volk HD, Lode HN, Zenclussen AC. Supporting the hypothesis of pregnancy as a tumor: survivin is upregulated in normal pregnant mice and participates in human trophoblast proliferation. Am J Reprod Immunol 2008, 59:75-83. 10.1111/j.1600-0897.2007.00557.x, 18154598.
53. Cobellis L, De Falco M, Torella M, Trabucco E, Caprio F, Federico E, Manente L, Coppola G, Laforgia V, Cassandro R, Colacurci N, De Luca A. Modulation of Bax expression in physiological and pathological human placentas throughout pregnancy. In Vivo 2007, 21:777-783.
54. Tayade C, Black GP, Fang Y, Croy BA. Differential gene expression in endometrium, endometrial lymphocytes, and trophoblasts during successful and abortive embryo implantation. J Immunol 2006, 176:148-156.
55. Savion S, Lepsky E, Orenstein H, Carp H, Shepshelovich J, Torchinsky A, Fein A, Toder V. Apoptosis in the uterus of mice with pregnancy loss. Am J Reprod Immunol 2002, 47:118-127. 10.1034/j.1600-0897.2002.1o027.x, 11900597.